Internewscast
Image default
Home » FDA approves Gilead’s remdesivir as a treatment for coronavirus patients
Health News

FDA approves Gilead’s remdesivir as a treatment for coronavirus patients

The US Food and Drug Administration (FDA) has given full approval to the antiviral drug remdesivir as a coronavirus treatment.

Manufactured by California-based Gilead Sciences Inc, the medication was the only approved for emergency use in the US to treat severely ill COVID-19 patients.

According to the FDA’s website says the drug has been approved in two forms: five milligrams (mg) per milliliter dropper and 100 mg per vial.

A recent study from the National Institutes of Health found that remdesivir shortened coronavirus hospital stays by five days and reduces the risk of death by 30 percent. 

On Thursday, the FDA approved the antiviral drug remdesivir (pictured) as a treatment for coronavirus patients

On Thursday, the FDA approved the antiviral drug remdesivir (pictured) as a treatment for coronavirus patients

On Thursday, the FDA approved the antiviral drug remdesivir (pictured) as a treatment for coronavirus patients

This is a breaking news story and will be updated. 

Source: Daily Mail

Related posts

Proposal on Brooklyn Bridge doesn’t quite go to plan as photographer gets whacked by cyclist 

InterNewsCast

Seton Hall’s COVID-19 quarantine coming to an end

InterNewsCast

One large bet drops enormous Jets-Chiefs line

InterNewsCast

Leave a Comment